Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep761 | Thyroid | ECE2021

Management and outcome of Graves orbitopathy

Hiba-Allah Chatti , Oueslati Ibtissem , Laamouri Rihab , Yazidi Meriem , Chaker Fatma , Chihaoui Melika

IntroductionGraves orbitopathy is the main extra thyroidal manifestation of Graves’ disease, though severe forms are rare (< 5%). Management of Graves orbitopathy is often suboptimal, largely because available treatments do not target pathogenic mechanisms of the disease. The aim of our study was to evaluate different treatment modalities and assess their impact on the outcome of Graves orbitopathy.Patients and methods...

ea0073ep134 | General Endocrinology | ECE2021

Autoimmune polyglandular syndrome type 3: a case report

Besrour Chayma , Rojbi Imen , Laamouri Rihab , Lakhoua Youssef , Mchirgui Nadia , Ben Nacef Ibtissem , Khiari Karima

IntroductionAutoimmune polyglandular syndrome (APS) is a rare endocrinopathy, characterized by the coexistence of two or more glandular autoimmune diseases that can appear at different intervals of time.ObservationHerein the case of a young woman descendant of first degree consanguineous marriage, diagnosed since the age of six with celiac disease (CD) where gluten-free diet was not respected due to poor soci...

ea0073ep225 | Thyroid | ECE2021

Pancytopenia in Grave’s disease: due to ATD or other autoimmune disease ?

Besrour Chayma , Rojbi Imen , Laamouri Rihab , Lakhoua Youssef , Mchirgui Nadia , Ben Nacef Ibtissem , Khiari Karima

IntroductionGrave’s disease is an autoimmune disease characterized by hyperthyroidism. It is in some cases associated to more autoimmune organs dysfunction. The antithyroid drugs are the first line treatement, and sometimes they are responsible for severe adverse effects.ObservationWe report the case of a 34 year-old man, treated for his grave’s disease with thiamazol for two years. Two weeks after ...

ea0099p391 | Late-Breaking | ECE2024

Surgical outcomes in primary hyperparathyroidism: addressing factors predicting persistent or recurrent hyperparathyroidism

Merhbene Yesmine , Laamouri Rihab , Mekni Sabrine , Essayeh Sawsen , Khiari Karima , Mchirgui Nadia , Rojbi Imen , Ibtissem Bennacef

Background: Primary hyperparathyroidism is a common endocrine disorder characterized by hypercalcemia, resulting from excessive secretion of parathyroid hormone. Parathyroidectomy, is considered as the definitive treatment for this condition, leading in most cases to remission and resolution of hypercalcemia. However, some patients experience surgical failure. Persistent hyperparathyroidism is defined as persistence of hypercalcemia after parathyroidectomy or recurrence of hyp...

ea0099p399 | Late-Breaking | ECE2024

Persistent parathyroid hormone elevation post-parathyroidectomy with biological remission: prevalence and predictive factors

Merhbene Yesmine , Laamouri Rihab , Sawsen Essayeh , Mekni Sabrine , Khiari Karima , Mchirgui Nadia , Rojbi Imen , Ibtissem Bennacef

Background: Primary hyperparathyroidism, is defined by hypercalcemia associated with an elevated or inappropriately normal parathyroid hormone(PTH) levels stemming from hyperfunctioning parathyroid glands. It’s a prevalent endocrine disorder. Parathyroidectomy, the surgical excision of affected glands, stands as the definitive treatment, typically resulting in remission and normalization of calcium levels. However, persistent elevation of serum PTH post-parathyroidectomy ...

ea0099ep1041 | Thyroid | ECE2024

Subclinical hyperthyroidism: exploring etiologies, clinical profiles and outcomes

Myriam Baltagi , Essayeh Sawsen , Rojbi Imen , Ben Nacef Ibtissem , Mekni Sabrine , Laamouri Rihab , Khiari Karima

Introduction: Subclinical hyperthyroidism (SH) is defined by normal thyroid hormone levels and reduced thyroid-stimulating hormone (TSH) concentration. It still raises intriguing questions about its clinical impact, management and outcomes. The aim of our study was to determine the underlying etiologies of SH, its clinical features and its outcomes in Tunisian patients.Methods: We conducted a retrospective study at Charles Nicolle Hospital, including 46 ...

ea0073aep75 | Adrenal and Cardiovascular Endocrinology | ECE2021

Bilateral pheochromocytoma in von hippel-lindau syndrome revealed by a hemangioblastoma

Kamoun Elyes , Rojbi Imen , Laamouri Rihab , Majdoub Marwa , Besrour Chayma , Lakhoua Youssef , Mchirgui Nadia , Nacef Ibtissem Ben , Khiari Karima

IntroductionVon Hippel-Lindau (VHL) syndrome is an autosomal dominant disease resulting in a susceptibility to develop central nervous system and retinal hemangioblastomas, endolymphatic sac tumors, renal clear cell carcinoma and pheochromocytoma. Pheochromocytoma occurs usually at a younger age and tends to be bilateral in VHL syndrome. Herein, we describe a case of VHL syndrome with cerebellar hemangioblastoma, bilateral pheochromocytoma and kidney tum...

ea0073aep80 | Adrenal and Cardiovascular Endocrinology | ECE2021

A giant nonfunctioning adrenocortical carcinoma: A case report

Besrour Chayma , Rojbi Imen , Majdoub Marwa , Laamouri Rihab , Kamoun Elyes , Lakhoua Youssef , Mchirgui Nadia , Nacef Ibtissem Ben , Khiari Karima

IntroductionThe adrenocortical carcinoma(ACC) is a rare malignant tumor arising from the adrenal cortex, it is usually associated to abnormal hormone secretion, but sometimes it is nonfunctioning, leading to a delayed diagnosis with a locally advanced and/or a metastatic disease. ObservationWe report the case of a 42 year-old woman with no medical history who consulted for chronic epigastralgia. On physical e...

ea0073aep561 | Pituitary and Neuroendocrinology | ECE2021

A growth retardation revealing a pituitary stalk interruption syndrome: A case report

Laamouri Rihab , Aycha Ghachem , Rojbi Imen , Besrour Chayma , Lakhoua Youssef , Mchirgui Nadia , Ben Nacef Ibtissem , Khiari Karima

IntroductionPituitary stalk interruption syndrome is an entity radiologically defined by the association of an absent or thin pituitary stalk, an ectopic posterior lobe and a hypoplasia or aplasia anterior lobe. It can manifest as a several of hormonal deficiencies. The circumstances of discovery are multiple. This case illustrates a pituitary stalk interruption syndrome revealed by a growth retardation.Case presentation<p clas...

ea0073aep567 | Pituitary and Neuroendocrinology | ECE2021

Lymphocytic auto immune hypophysitis : A case report

Laamouri Rihab , Rojbi Imen , Besrour Chayma , Kamoun Elyes , Lakhoua Youssef , Mchirgui Nadia , Ben Nacef Ibtissem , Khiari Karima

IntroductionLymphocytic hypophysitis is an autoimmune inflammatory pathology of the pituitary gland responsible for partial or global hypopituitarism. In this context, we report a clinical case illustrating this entity.Clinical caseA 31-year-old woman with a family history of hypothyroidism and a personal history of vitiligo was seen in the 8th month of pregnancy for headaches that have progressed rapidly in ...